Nanologica Signs Collaboration Agreement with Zentiva for the use of NLAB Drug Delivery Platforms
A collaboration agreement for the use of the NLAB drug delivery platforms has been signed with Zentiva, a pharmaceutical company operating in Europe and beyond. The aim of this collaboration agreement is to simplify the contract process for future product-specific agreements.The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will be signed separately under this collaboration agreement. ” We first met Zentiva during BIO-Europe in 2019. Since then, we have had a continuous dialogue as they see